PPAR𝛾 Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study

Table 1

Clinical characteristics of study participants.

	Treatment group
	Control	Pioglitazone	P value
N	20	9
Age (years)	63.9±10.0	61.8±5.7	>.05
Waist Circumference (cm)	96.5±13.6	91.8±4.0	>.05
BMI (kg/m^2)	24.4±3.7	23.4±3.1	>.05
VFA (cm^2)	130.0±61.2	146.1±40.9	>.05
SFA (cm^2)	151.5±60.5	141.8±53.5	>.05

Data are expressed as mean±SD.